Go to article
Posted by CoV Report on September 24, 2021 8:58 amTags: Categories: Global Stories
The two antibodies, casirivimab and imdevimab, should be given to people infected with COVID-19 who are at highest risk of hospitalization or who have weak immune systems.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus
Leave a Reply